CTi, Cryptocurrency, and Market Cycles

In light of recent market turbulence, we thought it might be helpful to share our thoughts. All of us emerging market participants are aware that all new technology breakthroughs carry great opportunity as well as significant risk. Intuitively we understand that the reward versus the risk is asymmetric, that is to say, the potential upside exponentially exceeds the downside.

Still, knowing a thing is far different from experiencing it. Knowing fire burns does little to prepare you for burning your finger. Similarly, we know that when crypto assets double or triple in a month, at some point they must experience stomach churning reversals to the downside.

Upside and downside are both parts of any market cycle, powered by opportunity and uncertainty respectively. Cycles are neither good nor bad — they are natural. Peak euphoria provides the opportunity for the world to dream about the future. Rock-bottom despair forces practicality and clarity. When things are good, they’re never as good as they seem; when things are bad, they’re never as bad as they seem.

While all markets experience cycles, crypto has experienced more extreme swings because it is still a nascent market with a relatively small total market cap, and it’s goal is to redefine multiple large, global markets: money, finance, and the internet itself.

Despite downturns that would spell doomsday in legacy markets, the blockchain asset space has emerged from every cycle stronger than it entered. This is true across all key metrics: entrepreneurial and developer activity, academic research, infrastructural maturity, corporate adoption, public awareness, and price valuation, amongst others. Zooming out, cycles can be reframed as volatile periods around a relatively consistent adoption curve.

Effectively maneuvering crypto cycles is crucial for projects. In bear markets, keep your head down and build, build, build. As Coinbase did in 2017, when things are going well it’s time to foster resiliency and set up for success no matter what the future holds.

ClinTex certainly is and we hope you embrace that opportunity with us.

Productive v. Speculative Assets

Wherever we are in the current cycle, the past six week’s rise of highly speculative tokens (e.g., dog coins) most likely contributed to the current market correction.

We saw this towards the end of the ICO era of 2017, where speculation on valuations far exceeded the potential of many projects. There also weren’t many projects that qualified as functioning productive assets. Unlike the 2017 boom and 2018 bust, this time there are a slew of projects that are productive assets. Uniswap does billions of dollars in volume every day. Aave’s daily deposit volume routinely tops 100 million. It’s no coincidence that both Uniswap and Aave started in the last cycle. Monaco/MCO was an ICO from 2017 that persevered through the bear market, rebranding to crypto.com, and is now a successful hub for crypto.

It takes time and dedication to develop a product. It takes a bear market to test the resiliency and longevity of a team and its project.

CTi is very different from the dog coins and other projects that sprang up in the past couple of months. These speculative tokens have seen their market caps increase exponentially without any discernible reason to warrant the market cap. Conversely, we are on track to transform CTi into a productive asset in less than eight weeks. We will have revenue and customers. Through our interviews, posts on Medium, and interactions on social media, it is our hope that we have adequately conveyed to our community just how committed we are developing a real world use case and real world value proposition, via our technology.

The inspiration behind CTi started in 2014. It was born of decades of first hand experience of the problems and delays in clinical trials, and the recognition that blockchain could have a dramatic impact. The ClinTex team began working in earnest on the Clinical Trials Intelligence platform in 2018, the bear market. Our project actually came to life after the previous crypto market drawdown, since then we have focused, kept our heads down and now we are beginning to thrive. Coming through these early startup times has made us resilient and dedicated.

That is why ClinTex remains focused on what matters the most — our core mission of using data and blockchain technology to remove inequity, inefficiency and unfairness for the benefit of patients, the industry and of course, our token holders.

We have a viable business plan with the experience and connections to make it happen. Having started in 2018, we know all too well that the cycle is tough. Our team draws upon experience both within crypto and the clinical trials industry. We designed the CTi token as a critical piece of the project, not some tacked on token useful only for speculation. Like the projects mentioned above, CTi token holders and our community will ultimately be rewarded for investing in a project that does productive work.

Not only that, CTi’s use of blockchain technology will have a positive impact on people’s health and happiness, long into the future.

We seek to use blockchain to drive a positive change in the world through ensuring expedited medicine delivery, something we believe transcends the standard ups and downs of the cryptocurrency market.

We invite you all to join us on this journey together, ClinTex and our team is going nowhere and the future looks very bright indeed.

About ClinTex

ClinTex are a solution provider to the pharmaceutical industry, and the team behind CTi — Clinical Trials Intelligence: a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials.

Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.

Follow Us:

Clinical Trials Intelligence is a data management software solution for the clinical trials industry that leverages distributed ledger technology